Provexis (PXS) Competitors GBX 0.62 0.00 (0.00%) As of 10/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock PXS vs. NSH, ALK, CLCO, ICON, PAA, GEL, MMP, AAL, CCL, and GNKShould you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Norish (NSH), Alkemy Capital Investments (ALK), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Anglo American (AAL), Carnival Co. & (CCL), and Greene King (GNK). These companies are all part of the "transportation" industry. Provexis vs. Its Competitors Norish Alkemy Capital Investments CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Anglo American Carnival Co. & Greene King Provexis (LON:PXS) and Norish (LON:NSH) are both small-cap transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership. Is PXS or NSH more profitable? Norish has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Norish's return on equity of 0.00% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets Provexis-73.10% -68.68% -56.14% Norish N/A N/A N/A Do insiders and institutionals believe in PXS or NSH? 7.9% of Provexis shares are owned by institutional investors. 11.8% of Provexis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor PXS or NSH? In the previous week, Provexis' average media sentiment score of 0.00 equaled Norish'saverage media sentiment score. Company Overall Sentiment Provexis Neutral Norish Neutral Which has better earnings and valuation, PXS or NSH? Norish has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than Norish, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProvexis£1.20M12.07-£619.15K-£0.00-2,058.33Norish£36.39M0.00N/A£6.10N/A SummaryNorish beats Provexis on 6 of the 8 factors compared between the two stocks. Get Provexis News Delivered to You Automatically Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXS vs. The Competition Export to ExcelMetricProvexisDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£14.49M£1.72B£6.01B£2.59BDividend Yield5.06%2.95%5.66%5.28%P/E Ratio-2,058.33116.2885.354,388.05Price / Sales12.071,585.93583.22100,187.79Price / CashN/A10.3738.3227.90Price / Book71.9911.4712.728.71Net Income-£619.15K£20.70B£3.30B£5.89B7 Day PerformanceN/A-0.73%1.05%-0.06%1 Month Performance-10.12%2.61%7.56%2.40%1 Year Performance8.33%9.04%79.69%145.49% Provexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXSProvexisN/AGBX 0.62flatN/AN/A£14.49M£1.20M-2,058.334NSHNorishN/AN/AN/AN/A£52.62M£36.39M28.691,251Gap UpALKAlkemy Capital InvestmentsN/AGBX 179.50+2.6%N/A+407.0%£17.29MN/A-1,108.0225,500News CoverageCLCOCloudCoCo GroupN/AGBX 0.25+11.1%N/A+138.1%£1.59M£7.79M277.78125Gap UpICONIconic LabsN/AGBX 2.60-5.5%N/A-36.4%£381KN/A-64.203Gap DownPAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660AALAnglo American0.8372 of 5 starsGBX 2,804.94+1.4%GBX 2,216-21.0%+28.3%£29.55B£26.66B-718.74129,700Analyst UpgradeCCLCarnival Co. &N/AGBX 1,971.50+0.4%N/A+41.1%£26.62B£26.23B1,016.2440,000GNKGreene KingN/AN/AN/AN/A£2.63B£2.22B21.941,010High Trading Volume Related Companies and Tools Related Companies Norish Alternatives Alkemy Capital Investments Alternatives CloudCoCo Group Alternatives Iconic Labs Alternatives 22532 (PAA.L) Alternatives Greka Engineering & Technology Alternatives Marwyn Management Partners Alternatives Anglo American Alternatives Carnival Co. & Alternatives Greene King Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PXS) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
